Ignite Creation Date:
2024-05-05 @ 4:48 PM
Last Modification Date:
2024-10-26 @ 9:24 AM
Study NCT ID:
NCT00317720
Status:
COMPLETED
Last Update Posted:
2023-10-17
First Post:
2006-04-21
Brief Title:
Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 HER-2 Overexpressing Breast Cancer
Sponsor:
Organization:
MD Anderson Cancer Center